While Foundayo’s insulin-matching potential in type 2 diabetes had been established in a topline readout earlier this year, ...

Taiho Pharmaceuticals, together with U.S.-based subsidiary Taiho Oncology, has inched closer to approval of another oral ...

Real Chemistry has created an artificial intelligence-enabled platform to improve a manual, fragmented stage of the ...

Just months after trimming jobs in New Jersey following an acquisition, BioMarin is laying off 117 employees in California as ...

Come year’s end, more than 100 Novo employees reporting to the Danish drugmaker’s outpost in Plainsboro, New Jersey, will be ...

Injectables juggernaut Fresenius Kabi has been hit with an FDA warning letter, the second for the Fresenius group in less than a month. | The agency raised concerns about contamination and quality ...

The start-up, which deploys unmanned, reusable rockets into Earth’s low-orbit, secured another $251 million in a series D ...

The European Commission has revoked the EU marketing authorization for Hansoh Pharma’s lung cancer drug Aumseqa (aumolertinib ...

Bookended by its first commercial-scale manufacturing of the radioisotope actinium-225 in January and an expected ...

CSL Seqirus, a unit of the Australian biopharma CSL, is touting a surplus of its influenza vaccines in the U.S. ahead of the ...

Alnylam Pharmaceuticals has teamed up with Pete Shaw, making the retired professional football player the star of its “Play ...

In Milan this week, Novo and Eli Lilly took the stage at the European Association for the Study of Diabetes 2026 meeting with ...